CHU De Rouen

The medical center is at the forefront of transplant immunology, focusing on innovative approaches to improve outcomes for kidney transplant recipients. The center's research is dedicated to enhancing the understanding of immune responses in sensitized patients, particularly those without pre-existing donor-specific antibodies.

• Acute Rejection Prevention
• Immunosuppressive Therapies
• Biopsy-Proven Acute Rejection (BPAR) Studies

Through its pioneering work, the center contributes significantly to the development of more effective immunosuppressive strategies, such as the comparison of rATG and basiliximab, to prevent acute rejection in kidney transplant recipients.